InicioPodcastsThe Long Run with Luke TimmermanEp195: Ken Song on T-cell Engagers for Autoimmune DiseasesThe Long Run with Luke TimmermanEp195: Ken Song on T-cell Engagers for Autoimmune Diseases3 de marzo de 2026 · 1 h 6 minReproducir episodioCompartir desde este puntoNotas del episodioKen Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.Todos los episodios de The Long Run with Luke Timmerman